A Study of ARGX-110 in Patients With Nasopharyngeal Carcinoma (NPC)

Condition:   Cancer
Intervention:   Drug: ARGX-110
Sponsor:   arGEN-X BVBA
Recruiting - verified April 2016

from #ENT via xlomafota13 on Inoreader http://ift.tt/1rt9Psd
via IFTTT